CRCharlotte Ramdass

Charlotte Ramdass

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Charlotte Ramdass has a total of 6 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Short‐ and Long‐Term Clinical Outcomes of Preeclampsia in Women and Their Neonates in Pregnancies With and Without HIV Infection

    by Charlotte Ramdass, Jagidesa Moodley, Nnabuike Chibuoke Ngene, Nalini Govender

    Preeclampsia (PE) is characterized by new‐onset hypertension at or after 20 weeks of pregnancy, associated with either uteroplacental dysfunction and/or maternal organ dysfunction that involves any of the hematological, renal, hepatic, cardiovascular, and central nervous systems. It complicates 2%–8% of pregnancies worldwide and is a significant contributor to maternal and perinatal morbidity and mortality. The multiorgan involvement in PE may extend beyond the immediate puerperium period and significantly impact the health of both affected women and their children in later life. In sub‐Saharan Africa, long‐term data on PE remain limited, irrespective of the substantial HIV burden in the region and the probable interaction between hypertensive disorders of pregnancy, HIV infection, and antiretroviral therapy. Therefore, this narrative review provides an update on the short‐ and long‐term clinical outcomes of PE in the context of HIV infection, for both the mother and affected child. For instance, there is an increased risk of long‐term cardiovascular disease development and renal impairment in the mother. Neonates born from such pregnancies are also at increased risk of low birth weight and the sequelae of prematurity.

  • Open Access

    COVID‐19 and Maternal–Neonatal Outcomes: A South African Retrospective Analysis

    by Charlotte Ramdass, Sapna Ramdin, Jagidesa Moodley, Stanley Chibuzor Onwubu, Randolph Green-Thompson, Nalini Govender

    Background: The maternal and neonatal outcomes of COVID‐19 in South Africa are under‐reported. This retrospective study therefore examined how the national COVID‐19 lockdown influenced access to antenatal care and its associated effects on maternal and neonatal outcomes at a South African tertiary hospital before and during the pandemic. Methods: The study was based on data obtained from the birth registry records of a tertiary hospital in KwaZulu‐Natal between pre‐COVID‐19 (March 2019–February 2020) and during the pandemic (March 2020–December 2020). No COVID‐19 diagnostic data was recorded and only singleton pregnancies were included. Unpaired t ‐tests and Pearson’s chi‐square tests were used to compare continuous and categorical variables, respectively. Binary logistic regression was done to evaluate associations between maternal features and labour complications. Results: A total of 8473 women accessed the hospital prior to ( n = 4866) and during the pandemic ( n = 3607). The majority of women attending the hospital during both time periods were aged between 19 and 35 years. Gestational age at delivery was significantly reduced during the pandemic (37.02 ± 4.10) versus the period prior (37.45 ± 3.74; p < 0.001). Additionally, during the pandemic, elective caesarean births increased significantly (10.31% vs. 6.33%), and the number of live births declined (3493 vs. 4705; p < 0.01). Rates of postpartum haemorrhage (1.95% vs. 0.56%), pre‐eclampsia (2.70% vs. 1.28%), sepsis (9.37% vs. 1.15%) and obstructed/prolonged childbirth (1.98% vs. 0.72%) increased significantly during the pandemic ( p < 0.01). Notably, during the pandemic, a 32‐fold increase in the risk of eclampsia (OR: 32.71; 95% CI: 4.31, 247.91; p = 0.001) was noted amongst primigravidae, with a higher risk of stillbirth in women aged between 19 and 35 (OR: 1.92; 95% CI: 1.14, 3.24; p < 0.05). Conclusion: We report a significant rise in maternal and neonatal complications during the pandemic. Our findings can be utilised to assess the risks, benefits and impact of various health interventions on affected individuals in similar disease settings, to improve maternal and neonatal health and decrease disease burden in LMICs.